CDMO.Avid Bioservices, INC

Form 4: Avid Bioservices CFO Daniel R. Hart Reports Stock Purchase Under Employee Stock Purchase Plan

Sentiment:

SEC Form 4 Filing

📋All filings for Avid Bioservices, INC
🔒Login to Follow

Daniel R. Hart, CFO of Avid Bioservices, Inc., reports the purchase of common stock under the company's Employee Stock Purchase Plan.

Summary

  • On June 28, 2024, Daniel R. Hart, the Chief Financial Officer of Avid Bioservices, Inc. (CDMO), acquired 1,965 shares of common stock.
  • The shares were purchased at a price of $5.406 per share.
  • This transaction was part of the company's Employee Stock Purchase Plan (ESPP).
  • Following the transaction, Hart directly owns 84,186 shares of Avid Bioservices, Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document simply reports a routine stock purchase by an executive under an existing employee stock purchase plan. It doesn't inherently indicate positive or negative news about the company's performance.

Positives

  • The purchase of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Executive stock purchases are common and often viewed as a sign of management's confidence in the company's performance and future prospects. These transactions are closely monitored by investors for insights into management's sentiment.

Comparison to Industry Standards

  • Executive compensation packages often include stock options or the opportunity to participate in employee stock purchase plans.
  • The details of these plans, such as the discount offered (in this case, 15%), are generally in line with industry standards.
  • Comparing the frequency and size of insider transactions at Avid Bioservices to those of its peers (e.g., other contract development and manufacturing organizations) could provide further context.

Stakeholder Impact

  • The transaction may have a minor positive impact on shareholder sentiment, as it reflects confidence from a key executive.

Key Dates

DateDescription
January 1, 2024Start of the ESPP offering period.
January 2, 2024Date used to determine the purchase price of shares under the ESPP (85% of the closing price).
June 28, 2024Date of the stock purchase transaction.
June 30, 2024End of the ESPP offering period.
July 02, 2024Date of signature for the Form 4 filing.

Keywords

Avid Bioservices, CDMO, Daniel R. Hart, CFO, Employee Stock Purchase Plan, ESPP, Stock Purchase, Form 4, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.